American Society of Clinical Oncology
Connections
Around the web
-
Biodesix to Announce Results of VeriStrat? Biomarker Study
results of the first completed biomarker-stratified, validation study in oncology will be presented at the 2013 American Society of Clinical Oncology (ASCO) Annual Meeting, May 31st – June 4th, 2013. The Randomized Proteomic Stratified Phase III Study of Second 5/21/13 from iStockAnalyst Read more »
-
New Research Proves Clinical Pathways Can Reduce Cancer Care Costs and Improve Quality While Increasing Physician Reimbursement
research being featured later this month in poster presentations and abstracts at the 49th Annual Meeting of the American Society of Clinical Oncology (ASCO) proves that it is possible to meet all three of these seemingly contrary goals. Cardinal Health Specialty from Virtual Press Office Read more »
-
BioMarin Announces BMN-673 Data in Breast and Ovarian Cancers to Be Released at ASCO
that data from its ongoing Phase 1/2 trial for BMN-673 for genetically-defined cancers will be released at the American Society of Clinical Oncology (ASCO) meeting in Chicago on June 3, 2013. At ASCO, the company will present data from 18 gBRCA breast cancer from Check Orphan Read more »
-
Cancer Genetics to Attend ASCO Annual Meeting
or the "Company"), a leader in oncology-focused personalized medicine, will attend for the first time the 2013 American Society of Clinical Oncology ("ASCO") Annual Meeting on May 31-June 4, 2013 at McCormick Place in Chicago. CGI will be at stand number 19120 from Daily Finance Read more »
-
TRACON Pharmaceuticals Announces TRC105 Clinical Trials, Abstract Presentations at 2013 ASCO Annual Meeting
clinical investigations for TRC105 and the presentation of two abstracts at the 49th Annual Meeting of the American Society of Clinical Oncology (ASCO), held May 31 to June 4 in Chicago. TRC105, a novel monoclonal antibody to endoglin (CD105), is being studied from Drugs.com Read more »
